-
2
-
-
0347596814
-
The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil
-
Li W, Thompson CH, Cossart YE, et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004;26:1.
-
(2004)
Head Neck
, vol.26
, pp. 1
-
-
Li, W.1
Thompson, C.H.2
Cossart, Y.E.3
-
3
-
-
70349256093
-
Cancer incidence and risk factors after solid organ transplantation
-
Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009;125:1747.
-
(2009)
Int J Cancer
, vol.125
, pp. 1747
-
-
Vajdic, C.M.1
Van Leeuwen, M.T.2
-
4
-
-
0035177929
-
Risk factors for development of de novo neoplasia after liver transplantation
-
Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001;7:971.
-
(2001)
Liver Transpl
, vol.7
, pp. 971
-
-
Xiol, X.1
Guardiola, J.2
Menendez, S.3
-
6
-
-
0030809592
-
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin
-
Jonas S, Rayes N, Neumann U, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997;80:1141.
-
(1997)
Cancer
, vol.80
, pp. 1141
-
-
Jonas, S.1
Rayes, N.2
Neumann, U.3
-
7
-
-
57849169437
-
Risk of malignant neoplasms after liver transplantation: A population-based study
-
Aberg F, Pukkala E, Hockerstedt K, et al. Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Transpl 2008;14:1428.
-
(2008)
Liver Transpl
, vol.14
, pp. 1428
-
-
Aberg, F.1
Pukkala, E.2
Hockerstedt, K.3
-
9
-
-
84859495333
-
De novo malignancies after liver transplantation: Incidence comparison with the korean cancer registry
-
Park HW, Hwang S, Ahn CS, et al. De novo malignancies after liver transplantation: Incidence comparison with the korean cancer registry. Transplant Proc 2012;44:802.
-
(2012)
Transplant Proc
, vol.44
, pp. 802
-
-
Park, H.W.1
Hwang, S.2
Ahn, C.S.3
-
10
-
-
0034883212
-
Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells
-
Szabo G, Gavala C, Mandrekar P. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J Investig Med 2001;49:442.
-
(2001)
J Investig Med
, vol.49
, pp. 442
-
-
Szabo, G.1
Gavala, C.2
Mandrekar, P.3
-
11
-
-
0026722491
-
Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype
-
Arceci RJ, Stieglitz K, Bierer BE. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 1992;80:1528.
-
(1992)
Blood
, vol.80
, pp. 1528
-
-
Arceci, R.J.1
Stieglitz, K.2
Bierer, B.E.3
-
12
-
-
77953286457
-
Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment
-
Martinez-Trufero J, Isla D, Adansa JC, et al. Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment. Br J Cancer 2010;102: 1687.
-
(2010)
Br J Cancer
, vol.102
, pp. 1687
-
-
Martinez-Trufero, J.1
Isla, D.2
Adansa, J.C.3
-
13
-
-
0036235128
-
First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/ leucovorin
-
Cassidy J, Twelves C, Van Cutsem E, et al. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/ leucovorin. Ann Oncol 2002;13:566.
-
(2002)
Ann Oncol
, vol.13
, pp. 566
-
-
Cassidy, J.1
Twelves, C.2
Van Cutsem, E.3
-
14
-
-
0036174497
-
Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: A single-institution experience
-
Abushullaih S, Saad ED, Munsell M, et al. Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: A single-institution experience. Cancer Invest 2002;20:3.
-
(2002)
Cancer Invest
, vol.20
, pp. 3
-
-
Abushullaih, S.1
Saad, E.D.2
Munsell, M.3
-
15
-
-
4444335026
-
Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy
-
Heo YS, Chang HM, Kim TW, et al. Hand-foot syndrome in patients treated with capecitabine-containing combination chemotherapy. J Clin Pharmacol 2004;44:1166.
-
(2004)
J Clin Pharmacol
, vol.44
, pp. 1166
-
-
Heo, Y.S.1
Chang, H.M.2
Kim, T.W.3
-
16
-
-
0035871538
-
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
-
Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. J Clin Oncol 2001;19:2282.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2282
-
-
Hoff, P.M.1
Ansari, R.2
Batist, G.3
-
17
-
-
0035503151
-
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study
-
Van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 2001;19:4097.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4097
-
-
Van Cutsem, E.1
Twelves, C.2
Cassidy, J.3
-
18
-
-
84874107117
-
Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
-
Epub ahead of print]; DOI: 10.1002/hed.21910
-
Shin DM, Khuri FR. Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck 2011[Epub ahead of print]; DOI: 10.1002/hed.21910.
-
(2011)
Head Neck
-
-
Shin, D.M.1
Khuri, F.R.2
-
19
-
-
34250155320
-
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer
-
Temam S, Kawaguchi H, El-Naggar AK, et al. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer. J Clin Oncol 2007;25:2164.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2164
-
-
Temam, S.1
Kawaguchi, H.2
El-Naggar, A.K.3
-
20
-
-
77953664765
-
Nimotuzumab,a promising therapeutic monoclonal for treatment of tumors of epithelial origin
-
Ramakrishnan MS, Eswaraiah A, Crombet T, et al. Nimotuzumab,a promising therapeutic monoclonal for treatment of tumors of epithelial origin. MAbs 2009;1:41.
-
(2009)
MAbs
, vol.1
, pp. 41
-
-
Ramakrishnan, M.S.1
Eswaraiah, A.2
Crombet, T.3
-
21
-
-
34247847993
-
Malignancies of the colorectum and anus in solid organ recipients
-
Aigner F, Boeckle E, Albright J, et al. Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 2007;20:497.
-
(2007)
Transpl Int
, vol.20
, pp. 497
-
-
Aigner, F.1
Boeckle, E.2
Albright, J.3
-
22
-
-
4544226050
-
Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression
-
Roka S, Rasoul-Rockenschaub S, Roka J, et al. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int 2004;17:366.
-
(2004)
Transpl Int
, vol.17
, pp. 366
-
-
Roka, S.1
Rasoul-Rockenschaub, S.2
Roka, J.3
-
24
-
-
33846961801
-
Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients
-
Bonatti H, Aigner F, De Clercq E, et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int 2007; 20:238.
-
(2007)
Transpl Int
, vol.20
, pp. 238
-
-
Bonatti, H.1
Aigner, F.2
De Clercq, E.3
-
25
-
-
85047700479
-
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control
-
Wiest T, Schwarz E, Enders C, et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002;21:1510.
-
(2002)
Oncogene
, vol.21
, pp. 1510
-
-
Wiest, T.1
Schwarz, E.2
Enders, C.3
-
26
-
-
77951457224
-
Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience
-
Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 2010;116:2166.
-
(2010)
Cancer
, vol.116
, pp. 2166
-
-
Singhi, A.D.1
Westra, W.H.2
-
27
-
-
33947140297
-
Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer
-
Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007;120: 1731.
-
(2007)
Int J Cancer
, vol.120
, pp. 1731
-
-
Reimers, N.1
Kasper, H.U.2
Weissenborn, S.J.3
|